BMY.RT

Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT

Overview Fund Activity
Delisted

BMY.RT was delisted on the 31st of December, 2020.

Back to rankings

3 hedge funds and large institutions have $3.59M invested in Bristol-Myers Squibb Company Contingent Value Rights in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.

Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
JCI
1
Jet Capital Investors
New York
$3.59M 2,661,301 – –
PDN
2
Pensionfund DSM Netherlands
Netherlands
– – -33,000 Closed
PS
3
Pensionfund Sabic
Netherlands
– – -23,000 Closed
MAM
4
Meeder Asset Management
Ohio
$0 5 +5 New
BCM
5
Beddow Capital Management
Wyoming
$0 572,879 +357,579 +166%